The DIA/ARCS Cell and Gene Therapy Summit unites Australia’s regional leaders with international experts and regulators for a powerful exchange on advancing the science, policy, and promise of cell and gene therapies. Together, we’ll explore solutions to accelerate innovation and expand global access to transformative treatments.

As investment, regulation, and innovation evolve globally, Australia stands at a pivotal moment ready to connect leading world-class research and clinical excellence with the opportunities of global manufacturing, regulatory harmonisation, and patient access.

Meeting participants will explore what it takes to move from basic research to clinical reality, build sustainable systems for equitable access, and position Australia as a leader and a central world hub for advanced therapies within the broader Asia-Pacific region.

Through interactive sessions and strategic discussions, participants will examine key trends, global insights, and practical pathways to connect research, regulation, and clinical delivery. Together, we will define how Australia can collaborate, compete, and lead in this transformative field ensuring the regional ecosystem is ready to deliver the next generation of precision cures to local, emerging and global markets.

View Agenda.